Through this new subsidiary, Genomma Lab will sell new product lines within the categories of analgesics, cold remedies, anti-fungal, anti-inflammatory, expectorants and multivitamins, among others.
Genomma Lab said that it will apply its strategy of manufacturing these new product lines through third parties, thereby maintaining the high-quality standards that are characteristic of the company.